Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal

Details for Australian Patent Application No. 2005300248 (hide)

Owner Transgene S.A.

Inventors Erbs, Philippe

Agent Davies Collison Cave

Pub. Number AU-B-2005300248

PCT Pub. Number WO2006/048768

Priority 60/646,595 26.01.05 US; 04360101.2 08.11.04 EP

Filing date 26 October 2005

Wipo publication date 11 May 2006

Acceptance publication date 26 April 2012

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 31/7052 (2006.01)

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/048768 Priority application(s): WO2006/048768

5 July 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal

26 April 2012 Application Accepted

  Published as AU-B-2005300248

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005300252-Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof

2005300241-Methods for preparing indazole compounds